Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | NQO1 | P15559 | 1/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20176224 | 0.81 | PDPK1 (0.41) | CYP19A1PDPK1RAB9AADORA2AADORA1 | |
| SCHEMBL31227185 | 0.79 | CYP2A6 (0.46) | CYP19A1PDPK1CYP2A6HSP90AA1CHUK | |
| SCHEMBL845603 | 0.76 | APP (0.63) | CYP19A1APPNQO1NQO2HSD17B1 | |
| SCHEMBL29732980 | 0.76 | APP (0.63) | CYP19A1APPNQO1NQO2HSD17B1 | |
| SCHEMBL31377493 | 0.76 | PDPK1 (0.44) | PDPK1RAB9AADORA2AADORA1SYK | |
| SCHEMBL2581028 | 0.76 | CYP19A1 (0.64) | CYP19A1APPNQO1NQO2HSD17B1 | |
| SCHEMBL26500159 | 0.76 | APP (0.50) | CYP19A1APPADORA2AADORA1NQO1 | |
| SCHEMBL27631108 | 0.75 | CYP19A1 (0.48) | CYP19A1APPNQO1NQO2HSD17B1 | |
| SCHEMBL16866899 | 0.74 | ADORA2A (0.46) | CYP19A1APPADORA2AADORA1NQO1 | |
| SCHEMBL29415478 | 0.73 | CYP19A1 (0.60) | CYP19A1RAB9AAPPPIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108558911-B | Polysubstituted benzothienothiazole and derivative and synthesis method thereof | 湘潭大学 | 2021-03-16 | — | — | CN | claimed |
| CN-113512047-A | Compound and application thereof | 北京鼎材科技有限公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-108558911-B | Polysubstituted benzothienothiazole and derivative and synthesis method thereof | 湘潭大学 | 2021-03-16 | — | — | CN | disclosed |
| CN-108558911-B | Polysubstituted benzothienothiazole and derivative and synthesis method thereof | 湘潭大学 | 2021-03-16 | — | — | CN | disclosed |
| CN-108558911-B | Polysubstituted benzothienothiazole and derivative and synthesis method thereof | 湘潭大学 | 2021-03-16 | — | — | CN | disclosed |
| US-20200392259-A1 | ORTHOMETALLATED CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION AND COPOLYMERIZATION | ARZOUMANIDIS GREGORY G (US) | 2020-12-17 | — | — | US | disclosed |
| US-20200227644-A1 | ORGANIC LIGHT-EMITTING DIODE OPERABLE AT LOW VOLTAGE WITH HIGH EFFICIENCY AND LONG LIFETIME | SFC CO., LTD. (KR) | 2020-07-16 | — | — | US | disclosed |
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
| CN-100443483-C | Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses | CHANGCHUN APPLIED CHEMISTRY (CN) | 2008-12-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | OR10J3, CRY1, NR2E3 | CYP19A1 68/4885PDPK1 4102/4885RAB9A 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.